Patent US4416866A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4416866A Expired / Lapsed US ⏱️ 0.0 years remaining

Diagnosis and treatment of fluke infections with monoclonal antibodies

Assignee: Johns Hopkins University
•
Filing: 1981-08-28
•
Granted: 1983-11-22
•
Expires: 2001-08-28
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Antibodies and antigens are disclosed which provide a method of detecting and a method of combating flukes. Fluke infections are screened by determining presence of fluke antigens defined by antibodies produced by hybridomas ATCC HB-8086 and HB-8087. Chronic and acute fluke infections are distinguished by determining presence of fluke spine protein. Fluke infections are combated by injecting warm-blooded animals with antibodies produced by hybridomas ATCC HB-8086, HB-8087 and HB-8088, or with proteins defined by those antibodies.

Inventors

  • 👤 Mette Strand

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-02 16:19
CPC Classifications
C; C07; C07K; C07K16/00; C07K16/18; C07K16/20; A; A61; A61K; A61K38/00

Claims Analysis

Total Claims: 13
Claim 1
Independent Claim 53 words
A screening method for the determination of a fluke infection of a warm-blooded animal which comprises testing a body component selected from the group consisting of serum, urine, milk and feces for the presence of glycoprotein molecules bound by antibodies produced by fused cell hybrid ATCC HB-8087 or fused cell hybrid ATCC HB-8086.
Claim 2
Dependent Claim 53 words
A screening method for the determination of a fluke infection of a warm-blooded animal which comprises testing a body component selected from the group consisting of serum, urine, milk and feces for the presence of glycoprotein molecules bound by antibodies produced by fused cell hybrid ATCC HB-8087 or fused cell hybrid ATCC HB-8086.
Claim 3
Dependent Claim 11 words
The method of claim 1 wherein the body component is urine.
Claim 4
Dependent Claim 11 words
The method of claim 1 wherein the body component is feces.
Claim 5
Dependent Claim 26 words
The method of claim 1 wherein said glycoprotein molecules are identified by an antibody assay selected from the group consisting of immunofluorescence, radioimmunoassay, and enzyme assay.
Claim 6
Dependent Claim 12 words
The method of claim 1 wherein said warm-blooded animal is a human.
Claim 7
Dependent Claim 47 words
A screening method for the determination of a fluke infection in a warm-blooded animal which comprises testing body serum for the presence of antibodies which bind glycoprotein molecules that are bound by the antibodies produced by fused cell hybrid ATCC HB-8087 or fused cell hybrid ATCC HB-8086.
Claim 8
Dependent Claim 47 words
A screening method for the determination of a fluke infection in a warm-blooded animal which comprises testing body serum for the presence of antibodies which bind glycoprotein molecules that are bound by the antibodies produced by fused cell hybrid ATCC HB-8087 or fused cell hybrid ATCC HB-8086.
Claim 9
Dependent Claim 10 words
The method of claim 6 wherein a human is tested.
Claim 10
Independent Claim 33 words
A method of combating fluke infection which comprises injecting a warm-blooded animal with a mixture of antibodies corresponding to the antibodies produced by fused cell hybrids ATCC HB-8086, ATCC HB-8087 and ATCC HB-8088.
Claim 11
Independent Claim 33 words
A method of combating fluke infection which comprises injecting a warm-blooded animal with a mixture of antibodies corresponding to the antibodies produced by fused cell hybrids ATCC HB-8086, ATCC HB-8087 and ATCC HB-8088.
Claim 12
Independent Claim 34 words
A method of combating fluke infection which comprises injecting a warm-blooded animal with a mixture of purified protein molecules bound by antibodies produced by fused cell hybrids ATCC HB-8086, ATCC HB-8087 and ATCC HB-8088.
Claim 13
Independent Claim 34 words
A method of combating fluke infection which comprises injecting a warm-blooded animal with a mixture of purified protein molecules bound by antibodies produced by fused cell hybrids ATCC HB-8086, ATCC HB-8087 and ATCC HB-8088.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1986-11-21 1987-05-23 1987-11-22 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1990-11-21 1991-05-23 1991-11-22 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1994-11-21 1995-05-23 1995-11-22 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag